Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

38.27

-0.52 (1.34%)

as of Jul 20, 2026, 8:00:00 pm Market Open.

171 watching

Investor Insights

Jul 20, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc (EXE-T) is positioned well to take advantage of the shifting demographics favoring home healthcare and long-term care. Experts highlight its strong market position, particularly in Ontario where government funding is increasing for home healthcare providers. The company has shown good margin management and is bouncing back from the pandemic, even though some analysts express caution regarding its share price, suggesting that much of its potential growth may already be reflected in current valuations. While there is appreciation for its asset-light model and effective management, some experts prefer other opportunities, citing the competitive landscape and relatively low growth outlook compared to its peers. Overall, the company has a positive growth trajectory with potential for mid to high $30s per share, but there are varying levels of enthusiasm among analysts regarding its valuation and growth prospects.

Consensus

Mixed

Valuation

Fair Value

Similar

CSH.UN

DON'T BUY

Model price is around the $7 area. Overvalued.

DON'T BUY

Has been a multi year disappointment. A lot of government regulations. Costs are high.

DON'T BUY

US state legislatures limit their revenues. For demographics, would prefer retirement homes.

BUY

A bit of a value play right now. Has a big asset in some hidden real estate assets. Solid.

WEAK BUY

Bad corporate governance.

DON'T BUY

Growth has not been as great as expected. Demographics for nursing facilities is too far off.

DON'T BUY

Fair market value is $3.

DON'T BUY

Tpp exposed to the swings of the operating income.

WEAK BUY

Prefers Sunrise instead.

BUY

Good story. Has been in and out of this stock several times. At a good price now.

WEAK BUY

Government issues in US could create severe problems.

STRONG BUY

Very profitable. Should continue to turn around

TOP PICK

Have sold some assets to pay down debt. Trades at a discount to its US peers.

BUY

Has undergone a significant turn around. Refocusing from Florida operations into Ontario.

DON'T BUY

Too overleveraged.

Showing 211 to 225 of 237 entries

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

David Driscoll

Liberty International Investment Management Inc

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Extendicare Inc (EXE.TO)